知镜 Cognispect · 医学文献与研究工作台

Epithelial PDGF-C Contributes to Crescentic Glomerulonephritis and FSGS in Part via Activation of Parietal Epithelial Cells.

Martin IV, Gao Y, Wong DWL, Bülow RD, Barsoum M, Nguyen L, van Swelm RPL, Boor P, Eriksson U, Lindenmeyer MT, Cohen CD, Panzer U, Krebs CF, Kramann R, Floege J, Raffetseder U, Smeets B, Braun GS, Stamellou E, Ostendorf T.
Journal of the American Society of Nephrology : JASN · 2026-10-09 · PMID 42853622

文献摘要

Key points PDGF-C was induced in activated parietal epithelial cells/podocytes along with PDGFR α in parietal epithelial cells/periglomerular cells in mouse models of crescentic glomerulonephritis/FSGS and human kidney samples. PDGF-C contributed in part to parietal epithelial cell activation and disease progression both in vitro and in all in vivo models of crescentic glomerulonephritis and FSGS. Presented in vitro and in vivo data supported a feed-forward interaction between PDGF-C and FOXM1. Background Activated parietal epithelial cells (PECs) and podocytes are key effector cells in the development of crescentic glomerulonephritis and FSGS. PDGF-C has been found to be important for tubulointerstitial fibrosis development, but its relevance for crescentic glomerulonephritis and FSGS was previously unknown. Methods To address this, expression analyses for both PDGF-C and its receptor PDGFR α were carried out in mouse and human kidney tissues. To further elucidate a functional role of PDGF-C, the murine nephrotoxic nephritis model of crescentic glomerulonephritis was induced in ( 1 ) Pdgfc -deficient mice, ( 2 ) mice treated with a neutralizing PDGF-C antibody, and ( 3 ) Pax8-cre::Pdgfcfl/fl mice with conditional Pdgfc deletion in kidney epithelial cells. We also subjected the collapsing FSGS model of the anti-Thy1.1 transgenic mouse to pharmacologic PDGF-C inhibition. The studies were supplemented by PEC in vitro analyses. Results Our data showed that PDGF-C was upregulated in PECs and expressed de novo in podocytes under disease conditions. It promoted the proliferation and activation of primary as well as conditionally immortalized PECs in vitro . In both the genetic and pharmacologic PDGF-C intervention studies in murine crescentic glomerulonephritis and FSGS, significant improvements in glomerular crescent formation, glomerular sclerosis, renal inflammation, and kidney function parameters were observed upon PDGF-C deficiency or antagonism. Mechanistically, transcription factor FOXM1 was identified as a mediator of disease-related PDGF-C expression in PECs. Conclusions Our studies identified epithelial PDGF-C as a contributor to disease progression in crescentic glomerulonephritis and FSGS, acting in part through the activation of PECs.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。